Skip to main content

Monte Rosa Therapeutics, Inc.

GLUE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001826457

In the last 90 days, Monte Rosa Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 192 institutions reported holding it in 13F filings for Q2 2026, worth $2.24B in total; Duquesne Family Office is the only superinvestor holding it.

13F holders, Q2 2026

Institutional positions in Monte Rosa Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
192
+4 vs. Q1 2026
Shares held
92.7M
+6.43M (+7.5%) vs. Q1 2026
Total value
$2.24B
+$823.4M (+58.0%) vs. Q1 2026
New holders
27
81 more added
Sold out
23
59 more reduced

3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting GLUE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 192 institutions
Q1 2021: 0 institutionsQ2 2021: 48 institutionsQ3 2021: 56 institutionsQ4 2021: 53 institutionsQ1 2022: 52 institutionsQ2 2022: 57 institutionsQ3 2022: 70 institutionsQ4 2022: 66 institutionsQ1 2023: 69 institutionsQ2 2023: 68 institutionsQ3 2023: 71 institutionsQ4 2023: 71 institutionsQ1 2024: 68 institutionsQ2 2024: 75 institutionsQ3 2024: 81 institutionsQ4 2024: 105 institutionsQ1 2025: 106 institutionsQ2 2025: 116 institutionsQ3 2025: 129 institutionsQ4 2025: 161 institutionsQ1 2026: 191 institutionsQ2 2026: 192 institutions
Value heldQ2 2026: $2.24B
Q1 2021: $0Q2 2021: $705.1MQ3 2021: $759.4MQ4 2021: $742.0MQ1 2022: $559.9MQ2 2022: $375.0MQ3 2022: $328.8MQ4 2022: $313.8MQ1 2023: $309.8MQ2 2023: $272.3MQ3 2023: $201.4MQ4 2023: $226.6MQ1 2024: $281.3MQ2 2024: $171.7MQ3 2024: $263.7MQ4 2024: $423.3MQ1 2025: $276.2MQ2 2025: $280.6MQ3 2025: $444.9MQ4 2025: $1.01BQ1 2026: $1.43BQ2 2026: $2.24B
Institutions holding GLUE and their total value by quarter
QuarterHoldersValue
Q2 2026192$2.24B
Q1 2026191$1.43B
Q4 2025161$1.01B
Q3 2025129$444.9M
Q2 2025116$280.6M
Q1 2025106$276.2M
Q4 2024105$423.3M
Q3 202481$263.7M
Q2 202475$171.7M
Q1 202468$281.3M
Q4 202371$226.6M
Q3 202371$201.4M
Q2 202368$272.3M
Q1 202369$309.8M
Q4 202266$313.8M
Q3 202270$328.8M
Q2 202257$375.0M
Q1 202252$559.9M
Q4 202153$742.0M
Q3 202156$759.4M
Q2 202148$705.1M
Q1 20210$0

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Monte Rosa Therapeutics, Inc.; share changes are against Q1 2026.

Institutions holding GLUE in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Principal Financial Group Inc49,001$1.19M0.00%+6,610+15.6%Added
SEI Investments Co50,028$1.21M0.00%−27,653−35.6%Reduced
California State Teachers Retirement System54,196$1.31M0.00%+50,907+1,547.8%Added
Quantinno Capital Management LP54,199$1.31M0.00%+196+0.4%Added
Massachusetts Financial Services Co54,328$1.31M0.00%−2,163−3.8%Reduced
Polygon Management Ltd.56,052$1.36M0.22%+56,052New
Rafferty Asset Management, LLC58,755$1.42M0.00%−45,866−43.8%Reduced
Alliancebernstein L.P.87,420$1.44M0.00%+31,720+56.9%Added
UBS Asset Management Americas Inc65,451$1.58M0.00%+46,172+239.5%Added
State of Wisconsin Investment Board66,706$1.61M0.00%−7,491−10.1%Reduced
Wells Fargo & Company68,650$1.66M0.00%+45,439+195.8%Added
Deutsche Bank AG75,061$1.82M0.00%+27,199+56.8%Added
JPMorgan Chase & Co76,820$1.84M0.00%+9,284+13.7%Added
Diadema Partners LP78,391$1.90M0.67%−108,916−58.1%Reduced
Zurcher Kantonalbank (Zurich Cantonalbank)79,122$1.91M0.00%+63,868+418.7%Added
Squarepoint Ops LLC82,953$2.01M0.00%+45,846+123.6%Added
Rhumbline Advisers94,593$2.29M0.00%+18,185+23.8%Added
Swiss National Bank96,300$2.33M0.00%+35,200+57.6%Added
Invesco Ltd.97,013$2.35M0.00%−5,184−5.1%Reduced
Renaissance Technologies LLC102,500$2.48M0.00%−276,600−73.0%Reduced
Jain Global LLC110,647$2.68M0.03%+110,647New
Atom Investors LP111,012$2.69M0.24%−83,464−42.9%Reduced
Caption Management, LLC112,322$2.72M0.10%+112,322New
Trexquant Investment LP115,363$2.79M0.02%+66,184+134.6%Added
ExodusPoint Capital Management, LP121,121$2.93M0.03%+121,121New
Citigroup Inc129,467$3.13M0.00%+114,892+788.3%Added
Exome Asset Management LLC137,115$3.32M2.05%−42,369−23.6%Reduced
Two Sigma Investments, LP140,923$3.41M0.00%+121,623+630.2%Added
StemPoint Capital LP153,544$3.72M0.64%+153,544New
Voya Investment Management LLC156,633$3.79M0.00%+74,294+90.2%Added
Citadel Advisors LLC163,571$3.96M0.00%−90,947−35.7%Reduced
Nuveen, LLC166,758$4.04M0.00%+45,886+38.0%Added
Victory Capital Management Inc168,512$4.08M0.00%+13,854+9.0%Added
D. E. Shaw & Co., Inc.172,053$4.16M0.00%+105,726+159.4%Added
Casdin Capital, LLC186,014$4.50M0.23%00.0%Unchanged
Franklin Resources Inc188,833$4.57M0.00%−10,889−5.5%Reduced
Manufacturers Life Insurance Company, The191,877$4.64M0.00%−17,924−8.5%Reduced
Balyasny Asset Management LLC198,895$4.81M0.01%−57,836−22.5%Reduced
Nomura Asset Management International Inc.200,000$4.84M0.01%00.0%Unchanged
UBS Group AG200,833$4.86M0.00%+48,213+31.6%Added
Wellington Management Group LLP207,427$5.02M0.00%+78,635+61.1%Added
ADAR1 Capital Management, LLC216,752$5.25M0.25%+1,000+0.5%Added
Longaeva Partners L.P.216,792$5.25M0.15%+216,792New
Bank of New York Mellon Corp222,521$5.39M0.00%+17,834+8.7%Added
Bank of America Corp254,561$6.16M0.00%−132,981−34.3%Reduced
TD Asset Management Inc285,936$6.92M0.01%−1,042−0.4%Reduced
Duquesne Family Office LLCSuperinvestorDuquesne Family Office297,600$7.20M0.17%+297,600New
Empowered Funds, LLC329,266$7.97M0.04%+23,868+7.8%Added
Allspring Global Investments Holdings, LLC352,857$8.54M0.01%−39,370−10.0%Reduced
Fisher Asset Management, LLC363,520$8.80M0.00%+48,658+15.5%Added
Alphabet Inc.372,474$9.01M0.01%−311,801−45.6%Reduced
Ameriprise Financial Inc383,335$9.28M0.00%+347,338+964.9%Added
Kennedy Capital Management, Inc.405,529$9.81M0.17%+373,552+1,168.2%Added
Adage Capital Partners GP, L.L.C.450,000$10.9M0.02%+200,000+80.0%Added
Parkwood LLC505,000$12.2M0.88%00.0%Unchanged
Vanguard Fiduciary Trust Co505,500$12.2M0.00%+98,422+24.2%Added
AQR Capital Management LLC520,648$12.6M0.00%−137,835−20.9%Reduced
Bridgeway Capital Management, LLC552,566$13.4M0.24%+23,868+4.5%Added
Boone Capital Management LLC615,287$14.9M3.48%+615,287New
Charles Schwab Investment Management Inc616,310$14.9M0.00%+69,621+12.7%Added
First Trust Advisors LP647,796$15.7M0.01%+647,796New
Nantahala Capital Management, LLC651,993$15.8M0.95%00.0%Unchanged
Northern Trust Corp652,087$15.8M0.00%−174,537−21.1%Reduced
Opaleye Management Inc.745,000$18.0M1.63%+745,000New
Nextech Invest, Ltd.761,153$18.4M0.87%+456,916+150.2%Added
Morgan Stanley789,545$19.1M0.00%+105,482+15.4%Added
Vanguard Portfolio Management LLC791,932$19.2M0.00%+275,966+53.5%Added
FMR LLC934,414$22.6M0.00%−89,890−8.8%Reduced
Woodline Partners LP962,884$23.3M0.07%+888,388+1,192.5%Added
Goldman Sachs Group Inc998,253$24.2M0.00%−3,274−0.3%Reduced
Frazier Life Sciences Management, L.P.1,000,000$24.2M0.53%00.0%Unchanged
Jupiter Topco LLC1,072,494$26.0M0.01%+1,072,494New
Silverarc Capital Management, LLC1,108,295$26.8M2.98%−893,745−44.6%Reduced
MPM Oncology Impact Management LP1,161,081$28.1M1.71%−15,847−1.3%Reduced
Dimensional Fund Advisors LP1,177,488$28.5M0.01%+136,116+13.1%Added
Bellevue Group AG1,190,000$28.8M0.61%−60,000−4.8%Reduced
Aisling Capital Management LP1,555,664$37.6M7.98%00.0%Unchanged
Marshall Wace, LLP1,593,600$38.6M0.03%+160,448+11.2%Added
American Century Companies Inc1,622,846$39.3M0.02%−1,186,801−42.2%Reduced
Geode Capital Management, LLC1,864,113$45.1M0.00%+323,301+21.0%Added
Braidwell LP2,451,562$59.3M2.19%−755,012−23.5%Reduced
Versant Venture Management, LLC3,180,780$77.0M47.34%00.0%Unchanged
Vanguard Capital Management LLC3,412,927$82.6M0.00%+312,682+10.1%Added
Suvretta Capital Management, LLC3,549,539$85.9M1.81%−677,270−16.0%Reduced
State Street Corp3,731,416$90.3M0.00%+377,436+11.3%Added
Baker Bros. Advisors LP4,345,736$105.2M0.53%00.0%Unchanged
BVF Inc4,460,886$108.0M2.76%00.0%Unchanged
Vestal Point Capital, LP4,600,000$111.3M2.60%+996,535+27.7%Added
TCG Crossover Management, LLC4,622,151$111.9M2.69%00.0%Unchanged
BlackRock, Inc.6,843,087$165.6M0.00%+1,205,403+21.4%Added
NEA Management Company, LLC7,692,298$186.2M11.72%00.0%Unchanged
Price T Rowe Associates Inc8,861,171$214.4M0.02%+2,140,983+31.9%Added
Arrowstreet Capital, Limited Partnership0$00.00%−647,739−100.0%Sold out
Cormorant Asset Management, LP0$00.00%−400,000−100.0%Sold out
Millennium Management LLC0$00.00%−191,382−100.0%Sold out
OpenArc Corporate Advisory, LLC0$00.00%−100,227−100.0%Sold out
Acadian Asset Management LLC0$00.00%−78,513−100.0%Sold out
Hussman Strategic Advisors, Inc.0$00.00%−63,000−100.0%Sold out
Prelude Capital Management, LLC0$00.00%−43,473−100.0%Sold out
Allstate Corp0$00.00%−27,956−100.0%Sold out